Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions.

Somkuwar SS, Jordan CJ, Kantak KM, Dwoskin LP.

Neuropsychopharmacology. 2013 Dec;38(13):2588-97. doi: 10.1038/npp.2013.163. Epub 2013 Jul 3.

2.

Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood.

Somkuwar SS, Darna M, Kantak KM, Dwoskin LP.

Biochem Pharmacol. 2013 Jul 15;86(2):309-16. doi: 10.1016/j.bcp.2013.04.013. Epub 2013 Apr 23.

3.

Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments.

Jordan CJ, Harvey RC, Baskin BB, Dwoskin LP, Kantak KM.

Drug Alcohol Depend. 2014 Jul 1;140:25-32. doi: 10.1016/j.drugalcdep.2014.04.020. Epub 2014 Apr 28.

4.

Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.

Harvey RC, Sen S, Deaciuc A, Dwoskin LP, Kantak KM.

Neuropsychopharmacology. 2011 Mar;36(4):837-47. doi: 10.1038/npp.2010.223. Epub 2010 Dec 8.

5.

Adolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood.

Jordan CJ, Taylor DM, Dwoskin LP, Kantak KM.

Behav Brain Res. 2016 Jan 15;297:165-79. doi: 10.1016/j.bbr.2015.10.017. Epub 2015 Oct 20.

6.

Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.

Somkuwar SS, Kantak KM, Dwoskin LP.

J Neurosci Methods. 2015 Aug 30;252:55-63. doi: 10.1016/j.jneumeth.2015.02.002. Epub 2015 Feb 11.

7.

Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments.

Harvey RC, Jordan CJ, Tassin DH, Moody KR, Dwoskin LP, Kantak KM.

Behav Brain Res. 2013 May 1;244:38-47. doi: 10.1016/j.bbr.2013.01.027. Epub 2013 Jan 31.

8.

Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.

Roessner V, Sagvolden T, Dasbanerjee T, Middleton FA, Faraone SV, Walaas SI, Becker A, Rothenberger A, Bock N.

Neuroscience. 2010 Jun 2;167(4):1183-91. doi: 10.1016/j.neuroscience.2010.02.073. Epub 2010 Mar 6.

PMID:
20211696
9.

Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorder.

Pandolfo P, Machado NJ, Köfalvi A, Takahashi RN, Cunha RA.

Eur Neuropsychopharmacol. 2013 Apr;23(4):317-28. doi: 10.1016/j.euroneuro.2012.04.011. Epub 2012 May 4.

PMID:
22561003
10.

Methylphenidate treatment beyond adolescence maintains increased cocaine self-administration in the spontaneously hypertensive rat model of attention deficit/hyperactivity disorder.

Baskin BM, Dwoskin LP, Kantak KM.

Pharmacol Biochem Behav. 2015 Apr;131:51-6. doi: 10.1016/j.pbb.2015.01.019. Epub 2015 Jan 31.

11.

Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.

Bradshaw SE, Agster KL, Waterhouse BD, McGaughy JA.

Brain Res. 2016 Jun 15;1641(Pt B):245-57. doi: 10.1016/j.brainres.2016.01.001. Epub 2016 Jan 14.

12.

Adolescent d-amphetamine treatment in a rodent model of attention deficit/hyperactivity disorder: impact on cocaine abuse vulnerability in adulthood.

Jordan CJ, Lemay C, Dwoskin LP, Kantak KM.

Psychopharmacology (Berl). 2016 Dec;233(23-24):3891-3903. Epub 2016 Sep 6.

PMID:
27600990
13.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
14.

Long Withdrawal of Methylphenidate Induces a Differential Response of the Dopaminergic System and Increases Sensitivity to Cocaine in the Prefrontal Cortex of Spontaneously Hypertensive Rats.

dos Santos Pereira M, Sathler MF, Valli Tda R, Marques RS, Ventura AL, Peccinalli NR, Fraga MC, Manhães AC, Kubrusly R.

PLoS One. 2015 Oct 28;10(10):e0141249. doi: 10.1371/journal.pone.0141249. eCollection 2015.

15.

Effect of cocaine on striatal dopamine clearance in a rat model of developmental stress and attention-deficit/hyperactivity disorder.

Womersley JS, Kellaway LA, Stein DJ, Gerhardt GA, Russell VA.

Stress. 2016;19(1):78-82. doi: 10.3109/10253890.2015.1096925. Epub 2015 Oct 20.

PMID:
26394534
16.

Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.

Somkuwar SS, Kantak KM, Bardo MT, Dwoskin LP.

Pharmacol Biochem Behav. 2016 Feb;141:66-77. doi: 10.1016/j.pbb.2015.12.002. Epub 2015 Dec 2.

17.

The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats.

Tamburella A, Micale V, Mazzola C, Salomone S, Drago F.

Eur J Pharmacol. 2012 May 15;683(1-3):148-54. doi: 10.1016/j.ejphar.2012.02.045. Epub 2012 Mar 8.

PMID:
22426162
18.

The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD.

Simchon Y, Weizman A, Rehavi M.

Eur Neuropsychopharmacol. 2010 Oct;20(10):714-20. doi: 10.1016/j.euroneuro.2010.04.007. Epub 2010 May 20.

PMID:
20493667
19.

5,7-Dihydroxy-6-methoxy-4'-phenoxyflavone, a derivative of oroxylin A improves attention-deficit/hyperactivity disorder (ADHD)-like behaviors in spontaneously hypertensive rats.

dela Peña IC, Young Yoon S, Kim Y, Park H, Man Kim K, Hoon Ryu J, Young Shin C, Hoon Cheong J.

Eur J Pharmacol. 2013 Sep 5;715(1-3):337-44. doi: 10.1016/j.ejphar.2013.05.002. Epub 2013 May 23.

PMID:
23707903
20.

Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.

Koda K, Ago Y, Cong Y, Kita Y, Takuma K, Matsuda T.

J Neurochem. 2010 Jul;114(1):259-70. doi: 10.1111/j.1471-4159.2010.06750.x. Epub 2010 Apr 16.

Supplemental Content

Support Center